Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children

Arthritis is one of the main manifestations of mixed connective tissue disease (MCTD) and overlap syndrome in children and can be responsible for functional disability. We report on 2 children with arthritis that were dramatically improved by a treatment with interleukin-6 (IL-6) blockers in the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera, Natalia, Duquesne, Agnes, Desjonquères, Marine, Larbre, Jean-Paul, Lega, Jean-Christophe, Fabien, Nicole, Belot, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Paediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030575/
https://www.ncbi.nlm.nih.gov/pubmed/27738519
http://dx.doi.org/10.1136/rmdopen-2016-000271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030575/
https://www.ncbi.nlm.nih.gov/pubmed/27738519
http://dx.doi.org/10.1136/rmdopen-2016-000271

Ejemplares similares